TW200738666A - Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors - Google Patents
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitorsInfo
- Publication number
- TW200738666A TW200738666A TW096102137A TW96102137A TW200738666A TW 200738666 A TW200738666 A TW 200738666A TW 096102137 A TW096102137 A TW 096102137A TW 96102137 A TW96102137 A TW 96102137A TW 200738666 A TW200738666 A TW 200738666A
- Authority
- TW
- Taiwan
- Prior art keywords
- gamma secretase
- secretase inhibitors
- thiochromane
- chromane
- tetrahydronaphthalene
- Prior art date
Links
- 239000003540 gamma secretase inhibitor Substances 0.000 title abstract 2
- ULFSJPZAKQORCD-UHFFFAOYSA-N 2-(benzenesulfonyl)-3,4-dihydro-2h-chromene Chemical compound C1CC2=CC=CC=C2OC1S(=O)(=O)C1=CC=CC=C1 ULFSJPZAKQORCD-UHFFFAOYSA-N 0.000 title 1
- WPWNEKFMGCWNPR-UHFFFAOYSA-N 3,4-dihydro-2h-thiochromene Chemical compound C1=CC=C2CCCSC2=C1 WPWNEKFMGCWNPR-UHFFFAOYSA-N 0.000 title 1
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/14—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/20—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/12—One of the condensed rings being a six-membered aromatic ring the other ring being at least seven-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76084206P | 2006-01-20 | 2006-01-20 | |
| US81487106P | 2006-06-19 | 2006-06-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200738666A true TW200738666A (en) | 2007-10-16 |
Family
ID=38171604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW096102137A TW200738666A (en) | 2006-01-20 | 2007-01-19 | Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8067621B2 (zh) |
| EP (1) | EP1976843B1 (zh) |
| JP (1) | JP5047992B2 (zh) |
| KR (1) | KR20080095885A (zh) |
| CN (1) | CN102702044A (zh) |
| AR (1) | AR059075A1 (zh) |
| AU (1) | AU2007207481B2 (zh) |
| BR (1) | BRPI0706685A2 (zh) |
| CA (1) | CA2637897A1 (zh) |
| EC (1) | ECSP088638A (zh) |
| IL (1) | IL192906A0 (zh) |
| MX (1) | MX2008009414A (zh) |
| NO (1) | NO20083598L (zh) |
| PE (1) | PE20071321A1 (zh) |
| RU (1) | RU2448964C2 (zh) |
| TW (1) | TW200738666A (zh) |
| WO (1) | WO2007084595A2 (zh) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007531742A (ja) * | 2004-04-05 | 2007-11-08 | シェーリング コーポレイション | 新規のγセクレターゼインヒビター |
| EP1789404B1 (en) * | 2004-06-30 | 2010-03-24 | Schering Corporation | Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors |
| CN102702044A (zh) | 2006-01-20 | 2012-10-03 | 先灵公司 | 作为γ分泌酶抑制剂的碳环和杂环芳基砜化合物 |
| BRPI0814256A8 (pt) * | 2007-07-05 | 2016-02-10 | Schering Corp | Inibidores de tetrahidropiranocromeno gama secretase |
| CL2008002084A1 (es) * | 2007-07-17 | 2009-01-23 | Schering Corp | Compuestos derivados de bencensulfonil cromano, tiocromano, tetrahidronaftaleno, inhibidores de la gamma secretasa; composicion farmaceutica que lo comprende; y su uso en la preparacion de medicamentos utiles para tratar enfermedades neurodegenerativas |
| CN102695546B (zh) | 2009-09-11 | 2014-09-10 | 前体生物药物股份公司 | 作为谷氨酰胺酰环化酶抑制剂的杂环衍生物 |
| US20110190269A1 (en) * | 2010-02-01 | 2011-08-04 | Karlheinz Baumann | Gamma secretase modulators |
| ES2602794T3 (es) | 2011-03-31 | 2017-02-22 | Pfizer Inc | Piridinonas bicíclicas novedosas |
| EP2693880A1 (en) * | 2011-04-04 | 2014-02-12 | Merck Sharp & Dohme Corp. | Gamma secretase inhibitors |
| EP2753623A4 (en) * | 2011-09-09 | 2015-01-28 | Merck Sharp & Dohme | GAMMASEKRETASEHEMMER |
| UA110688C2 (uk) * | 2012-09-21 | 2016-01-25 | Пфайзер Інк. | Біциклічні піридинони |
| US9464103B2 (en) * | 2012-11-29 | 2016-10-11 | Merck Sharp & Dohme Corp. | Spirocyclic sulfones as gamma secretase inhibitors |
| ES2665619T3 (es) | 2013-03-14 | 2018-04-26 | Novartis Ag | 3-Pirimidin-4-il-oxazolidin-2-onas como inhibidores de IDH mutante |
| US9643947B2 (en) | 2013-08-28 | 2017-05-09 | Northwestern University | 7-membered fused heterocycles and methods of their synthesis |
| DK3253755T3 (da) | 2015-02-03 | 2020-09-28 | Pfizer | Hidtil ukendte cyclopropabenzofuranyl-pyridopyrazindioner |
| KR102114536B1 (ko) | 2015-05-07 | 2020-05-22 | 브리스톨-마이어스 스큅 컴퍼니 | RORγ 조정제로서의 트리시클릭 술폰 |
| JP6983661B2 (ja) * | 2015-12-24 | 2021-12-17 | 協和キリン株式会社 | α、β不飽和アミド化合物 |
| EP3523279A1 (en) * | 2016-10-10 | 2019-08-14 | Bristol-Myers Squibb Company | Tricyclic sulfones as ror gamma modulators |
| ES2872005T3 (es) * | 2016-10-13 | 2021-11-02 | Bristol Myers Squibb Co | Sulfonas heterocíclicas como moduladores de ROR gamma |
| AR110152A1 (es) * | 2016-11-09 | 2019-02-27 | Bristol Myers Squibb Co | SULFONAS TRICÍCLICAS COMO MODULADORES DE RORg |
| US20230137562A1 (en) | 2017-06-07 | 2023-05-04 | Adrx, Inc. | Tau aggregation inhibitors |
| AU2018289759B2 (en) * | 2017-06-23 | 2022-03-10 | Kyowa Kirin Co., Ltd. | Alpha, beta-unsaturated amide compound |
| AU2018318319A1 (en) | 2017-08-18 | 2020-02-20 | Adrx, Inc. | Tau aggregation peptide inhibitors |
| PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
| JP2021524850A (ja) * | 2018-05-17 | 2021-09-16 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | RORγ調節剤としての三環スルホン化合物 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826967A (en) * | 1987-06-16 | 1989-05-02 | Naxcor | Psoralen-nucleoside adducts and method for their preparation |
| FR2639349B1 (fr) * | 1988-11-23 | 1991-02-22 | Sanofi Sa | Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant |
| CA2009664A1 (en) * | 1989-02-27 | 1990-08-27 | Philip Thiam Shin Lau | Tetrahydroquinolines and method of preparation |
| WO1992006970A1 (en) * | 1990-10-10 | 1992-04-30 | Schering Corporation | Bis-benzo cyclohepta piperidylidene, piperidine and piperazine compounds, compositions and methods of use |
| CN1048247C (zh) * | 1994-01-31 | 2000-01-12 | 美国辉瑞有限公司 | 神经保护的苯并二氢吡喃化合物 |
| DE19533023B4 (de) * | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| JP3810838B2 (ja) * | 1994-12-12 | 2006-08-16 | 三共アグロ株式会社 | 除草性イソオキサゾリン誘導体 |
| KR20020009383A (ko) * | 1998-04-01 | 2002-02-01 | 우에노 도시오 | 축합 티오펜 유도체 및 이의 유도체를 유효 성분으로 하는약제 |
| CZ20013000A3 (cs) | 1999-02-26 | 2002-02-13 | Merck & Co., Inc. | Nové sulfonamidové sloučeniny a jejich pouľití |
| PL372212A1 (en) | 2001-08-03 | 2005-07-11 | Schering Corporation | Novel gamma secretase inhibitors |
| GB0223039D0 (en) * | 2002-10-04 | 2002-11-13 | Merck Sharp & Dohme | Therapeutic compounds |
| ATE386028T1 (de) * | 2003-05-16 | 2008-03-15 | Merck Sharp & Dohme | Zyklohexylsulfone als gamma-sekretase-inhibitoren |
| EP1586561A1 (en) | 2004-04-13 | 2005-10-19 | Cephalon, Inc. | Bicyclic aromatic sulfinyl derivatives |
| EP1789404B1 (en) | 2004-06-30 | 2010-03-24 | Schering Corporation | Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors |
| CN102702044A (zh) | 2006-01-20 | 2012-10-03 | 先灵公司 | 作为γ分泌酶抑制剂的碳环和杂环芳基砜化合物 |
| TW200813054A (en) | 2006-06-02 | 2008-03-16 | Elan Pharm Inc | Fused, tricyclic sulfonamide inhibitors of gamma secretase |
| BRPI0814256A8 (pt) | 2007-07-05 | 2016-02-10 | Schering Corp | Inibidores de tetrahidropiranocromeno gama secretase |
-
2007
- 2007-01-18 CN CN2012101778321A patent/CN102702044A/zh active Pending
- 2007-01-18 PE PE2007000055A patent/PE20071321A1/es not_active Application Discontinuation
- 2007-01-18 KR KR1020087020378A patent/KR20080095885A/ko not_active Withdrawn
- 2007-01-18 CA CA002637897A patent/CA2637897A1/en not_active Abandoned
- 2007-01-18 RU RU2008133856/04A patent/RU2448964C2/ru not_active IP Right Cessation
- 2007-01-18 JP JP2008551381A patent/JP5047992B2/ja not_active Expired - Fee Related
- 2007-01-18 AR ARP070100225A patent/AR059075A1/es not_active Application Discontinuation
- 2007-01-18 AU AU2007207481A patent/AU2007207481B2/en not_active Ceased
- 2007-01-18 US US11/654,821 patent/US8067621B2/en active Active
- 2007-01-18 BR BRPI0706685-6A patent/BRPI0706685A2/pt not_active IP Right Cessation
- 2007-01-18 EP EP07716750.0A patent/EP1976843B1/en active Active
- 2007-01-18 MX MX2008009414A patent/MX2008009414A/es active IP Right Grant
- 2007-01-18 WO PCT/US2007/001302 patent/WO2007084595A2/en not_active Ceased
- 2007-01-19 TW TW096102137A patent/TW200738666A/zh unknown
-
2008
- 2008-07-17 IL IL192906A patent/IL192906A0/en unknown
- 2008-07-18 EC EC2008008638A patent/ECSP088638A/es unknown
- 2008-08-19 NO NO20083598A patent/NO20083598L/no not_active Application Discontinuation
-
2011
- 2011-10-06 US US13/267,324 patent/US8569521B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ECSP088638A (es) | 2008-08-29 |
| US20070197581A1 (en) | 2007-08-23 |
| CA2637897A1 (en) | 2007-07-26 |
| WO2007084595A2 (en) | 2007-07-26 |
| RU2008133856A (ru) | 2010-02-27 |
| JP2009528980A (ja) | 2009-08-13 |
| AU2007207481A1 (en) | 2007-07-26 |
| CN102702044A (zh) | 2012-10-03 |
| EP1976843A2 (en) | 2008-10-08 |
| MX2008009414A (es) | 2008-10-01 |
| KR20080095885A (ko) | 2008-10-29 |
| EP1976843B1 (en) | 2013-09-04 |
| BRPI0706685A2 (pt) | 2011-04-05 |
| WO2007084595A3 (en) | 2007-09-07 |
| US8067621B2 (en) | 2011-11-29 |
| US20120264736A1 (en) | 2012-10-18 |
| US8569521B2 (en) | 2013-10-29 |
| RU2448964C2 (ru) | 2012-04-27 |
| AR059075A1 (es) | 2008-03-12 |
| PE20071321A1 (es) | 2007-12-29 |
| NO20083598L (no) | 2008-10-20 |
| AU2007207481B2 (en) | 2012-08-23 |
| JP5047992B2 (ja) | 2012-10-10 |
| IL192906A0 (en) | 2009-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200738666A (en) | Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors | |
| MX2009011830A (es) | Compuestos amino-heterociclicos. | |
| MX2010006046A (es) | Moduladores de gamma secretasa. | |
| MY169274A (en) | Fused, tricyclic sulfonamide inhibitors of gamma secretase | |
| TW200718422A (en) | 1,6-Dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same | |
| PT1984357E (pt) | Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes | |
| TW200728305A (en) | Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease | |
| MX2012007273A (es) | Pteridinonas como inhibidores de la quinasa tipo polo. | |
| PT1902037E (pt) | 2,4-diamino-pirimidinas como inibidores de aurora | |
| SG162804A1 (en) | Pyrazole based lxr modulators | |
| IL181271A0 (en) | Triazolophthalazine derivatives and pharmaceutical compositions containing the same | |
| GB0305152D0 (en) | Organic compounds | |
| TW200801003A (en) | Novel compounds | |
| GT200600134A (es) | Compuestos novedosos de derivados de aminosulfonilo | |
| TW200510405A (en) | Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors | |
| JO2578B1 (en) | Compounds Theophene benzimidazole | |
| MX2007005221A (es) | Formas cristalinas de ascomicina y preparacion de ellas. | |
| MX2009007713A (es) | Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas. | |
| GT200400146A (es) | Derivados sustituidos del dioxido de tiazol-benzoisotiazol, procedimiento para su preparacion y su uso | |
| MX2009012525A (es) | Pirazol-pirrolidinas como inhibidores de gamma secretasa. | |
| PT2049480E (pt) | Derivados de 2-arilindole como inibidores da mpges-i | |
| ES2368594T3 (es) | Derivados sustituidos de ciclohexilmetilo. | |
| GT200600161A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos | |
| TW200722424A (en) | Substituted piperidines | |
| DE602006020295D1 (de) | Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel |